Glycomet 500mg SR
Generic: Metforminby USV Pvt Ltd

Similar medicines
View allAbout Glycomet 500mg SR
Glycomet 500 SR is USV Private Limited's slow release metformin: each tablet holds 500 mg of metformin hydrochloride in a sustained release form, meant to be taken once a day with the evening meal. The carton in our product photo reads "Metformin Hydrochloride Sustained Release Tablets IP 500 mg" and "Glycomet-500 S.R.", with the USV logo. We sell it in packs of 100, 200 and 300 tablets, from $0.62 a tablet in the 300 pack.
Before you order, three facts matter. Metformin needs a prescription in the US, UK, Australia and Canada, and a doctor who follows your HbA1c and kidney function. Slow release metformin is also cheap in the US: plain generic metformin ER 500 mg costs US pharmacies under 3 cents a tablet, so a US buyer with a prescription will almost certainly pay less locally. And our slow release tablet costs about 1.7 to 2 times as much as our standard Glycomet 500mg, so it is worth choosing only if your doctor wants you on the once daily form. The clinical facts below come from a current US extended release label (Ascend, September 2026) and the UK Glucophage SR label (Merck, revised March 2025), listed under Sources.
Glycomet 500 SR at a glance
| Active ingredient | Metformin hydrochloride 500 mg, sustained (slow) release |
| Brand and maker | Glycomet-500 S.R., USV Private Limited, Mumbai (carton in our product photo; PharmEasy, Apollo and Medkart listings) |
| Drug class | Biguanide |
| Regulatory status | Slow release metformin is licensed in the US (generic ER tablets), UK (Glucophage SR), Australia (Diabex XR) and Canada (Glumetza). This Indian Glycomet pack is not registered with the FDA, MHRA, TGA or Health Canada |
| Usual dose from the labels | Start with one 500 mg tablet once daily with the evening meal; raise in 500 mg steps (weekly in the US label, every 10 to 15 days in the UK label) to a maximum of 2,000 mg (four tablets) once daily. Your doctor sets the dose |
| Time to peak level | Median about 7 hours after a dose (US ER label 12.3); the UK label gives 7 hours against 2.5 hours for standard tablets (5.2) |
| Packs | 100, 200 and 300 tablets (the carton in our photo says 5 x 3 x 20 tablets, so strips of 20) |
| Price per tablet | $0.66 (100 pack) to $0.62 (300 pack), before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
What "SR" changes
The metformin is the same molecule as in standard tablets. What differs is how fast it leaves the tablet. In the US extended release label, the peak blood level arrives at a median of 7 hours (range 4 to 8) and is about 20% lower than after the same dose of standard metformin, while the total amount absorbed is comparable (12.3). The UK Glucophage SR label gives a peak at 7 hours against 2.5 hours for the immediate release tablet, and says 2,000 mg of the slow release form once daily gives a similar total exposure to 1,000 mg of standard tablets twice daily (5.2).
That slower release is why the slow release form is a once daily tablet, taken with the evening meal. Food matters more with this form: the US ER label says food raised the amount absorbed by about 50% (12.3), and the UK label says taking it fasting cut the amount absorbed by 30% (5.2). Take it with your evening meal, not on an empty stomach.
Two practical points follow from the slow release design:
- Swallow it whole. The US ER label says to swallow the tablets whole "and never crush, cut or chew" them (2.2). Our explanation: breaking the tablet can undo the slow release.
- You may see what looks like a tablet in your stool. The US ER patient information says: "You may sometimes pass a soft mass in your stools (bowel movement) that looks like metformin hydrochloride extended-release tablets. This is not harmful and will not affect the way metformin hydrochloride extended-release tablets works to control your diabetes." The UK Glucophage SR label says: "The tablet shells may be present in the faeces. Patients should be advised that this is normal." (4.4). These lines come from the US and UK products; USV's own leaflet was not available to us, so we cannot confirm the Glycomet SR tablet behaves the same way, although both labels describe it as normal for this kind of tablet.
Price per tablet
Prices are as of November 2026; the pack selector shows the current price.
| Pack | Price | Per tablet | Shipping | Per tablet with shipping |
|---|---|---|---|---|
| 100 tablets | $66 | $0.66 | $25 | $0.91 |
| 200 tablets | $128 | $0.64 | $25 | $0.77 |
| 300 tablets | $186 | $0.62 | Free | $0.62 |
The 300 pack is the cheapest per tablet before shipping as well as after it. It is also the only one of the three packs that passes the $149 free shipping line, which widens the gap once shipping is added.
Days per pack, our arithmetic at doses inside the label range (one to four tablets once daily):
| Pack | 500 mg a day (1 tablet) | 1,000 mg a day (2) | 1,500 mg a day (3) | 2,000 mg a day (4) |
|---|---|---|---|---|
| 100 tablets | 100 days | 50 days | 33 days | 25 days |
| 200 tablets | 200 days | 100 days | 66 days | 50 days |
| 300 tablets | 300 days | 150 days | 100 days | 75 days |
Most people start on one tablet and move up over several weeks, so the first pack often needs to cover changing doses. Settle the dose with your doctor before you buy 300 tablets, and check the expiry date printed on the strips when they arrive.
Compared with US generic metformin ER and our other metformin tablets
| Glycomet 500 SR (ours) | US generic metformin ER 500 mg (plain extended release) | |
|---|---|---|
| Maker | USV Private Limited, India | Several US generic makers |
| FDA approved | No (this pack is not registered with the FDA) | Yes |
| Cost per tablet | $0.62 to $0.66 before shipping | About $0.03 (NADAC $0.02841) |
| Cost per day at 1,000 mg (two tablets) | $1.24 to $1.32 before shipping | About $0.06 |
NADAC is the US Medicaid survey of what pharmacies pay to buy a medicine, not the shelf price a patient pays. In the NADAC file as of 4 November 2026, all 31 NDC rows for "METFORMIN HCL ER 500 MG TABLET", the plain extended release form, show $0.02841 a tablet, effective 21 October 2026. That is the fair comparison for Glycomet SR. NADAC also lists two pricier extended release forms that are not what we sell: osmotic tablets ("METFORMIN ER 500 MG OSMOTIC TB", 9 rows at $0.18913) and gastric retentive tablets ("METFORMIN ER 500 MG GASTRC-TB", 6 rows at $0.28306), all effective 21 October 2026. Our 500 SR tablet costs about 22 to 23 times the plain ER figure before shipping. If you are in the US and have a prescription, check US generic cash prices first; they are very likely to be lower than ours. The Glucophage XR brand is discontinued in the US, and the FDA records that this was not for reasons of safety or effectiveness.
Within our own range, the slow release tablet costs about 1.7 to 2 times the standard one: $0.62 to $0.66 a tablet here against $0.31 to $0.38 for Glycomet 500mg (immediate release), before shipping. If your doctor is happy for you to take standard metformin two or three times a day, that is the cheaper choice. Metsmall 1000 SR is another slow release metformin we sell, at $0.98 to $1.00 a 1,000 mg tablet before shipping, which works out cheaper per day than two Glycomet 500 SR tablets at 1,000 mg or more; it suits only people whose dose is in 1,000 mg steps.
Which strength to choose
| Product | Metformin per tablet | Release | Lowest price per tablet (before shipping) |
|---|---|---|---|
| Glycomet 500mg SR (this page) | 500 mg | Slow release, once daily | $0.62 |
| Glycomet 850mg SR | 850 mg | Slow release (check the strip) | $0.70 |
| Metsmall 1000 SR | 1,000 mg | Slow release | $0.98 |
| Glycomet 500mg | 500 mg | Immediate release, two or three times daily | $0.31 |
| Glycomet 850mg | 850 mg | Immediate release | $0.38 |
| Glycomet 1000mg | 1,000 mg | Check the strip | $0.72 |
How the 500 mg slow release tablet maps to the labels:
- Starting dose. Both the US ER label (2.2) and the UK Glucophage SR label (4.2) start new users on one 500 mg tablet once daily. This is the strength made for starting.
- Usual range. One to four tablets once daily (500 to 2,000 mg).
- Maximum. 2,000 mg a day, four tablets. If that does not control blood glucose, the US ER label says to "consider a trial" of 1,000 mg twice daily (2.2), and the UK label says 1,000 mg twice daily "should be considered", with both doses given with food (4.2).
- Above 2,000 mg. Neither label goes higher with slow release tablets. The US ER label says people needing more than 2,000 mg a day may switch to immediate release metformin, up to 2,550 mg (2.3); the UK label allows standard metformin up to 3,000 mg (4.2). Five or more Glycomet 500 SR tablets a day is above both labels.
Glycomet-GP tablets (for example Glycomet-GP 1) add glimepiride, a sulfonylurea, to metformin. They are a different medicine with a low blood sugar risk of their own.
Switching from standard metformin to Glycomet 500 SR
Many people meet slow release metformin after starting on standard tablets and having stomach trouble. The labels allow a direct switch, under a doctor's supervision:
- The US ER label says patients "may switch between metformin hydrochloride immediate-release tablets and metformin hydrochloride extended-release tablets at the same total daily dosage" (2.3). For example, 500 mg twice a day of standard tablets becomes two Glycomet 500 SR tablets once a day with the evening meal.
- The UK label says the starting dose of the slow release form "should be equivalent to the daily dose of metformin immediate release tablets", and that "In patients treated with metformin at a dose above 2000 mg daily, switching to Glucophage SR is not recommended." (4.2)
Expect some change in readings. In a 24 week US trial of people who had been taking standard metformin 500 mg twice a day for at least 8 weeks, HbA1c rose by 0.14 points in those who stayed on standard tablets, by 0.27 points on 1,000 mg slow release once daily and by 0.13 points on 1,500 mg slow release once daily (US ER label 14.2, Table 7). Check your glucose more often for the first few weeks after any switch, and let your doctor decide whether the dose needs to change. Do not switch on your own because a slow release pack was cheaper or easier to find.
How to take Glycomet 500 SR
- Take it once a day with your evening meal, unless your doctor has told you otherwise. Both the US ER label (2.2) and the UK label (4.2) set the evening meal as the dosing time.
- Swallow each tablet whole with water. Do not crush, cut or chew it (US ER label 2.2, 17).
- Go up slowly. The US ER label raises the dose by 500 mg weekly; the UK label adjusts it every 10 to 15 days and says "A slow increase of dose may improve gastro-intestinal tolerability."
- If you miss a dose, do not double up. The US ER label tells patients "not to take two doses the same day" and to restart with the next scheduled dose (2.2).
- Get your kidney function (eGFR) checked before starting and at least once a year; more often if you are older or your kidney function is falling (US ER label 5.1; UK label 4.2 gives every 3 to 6 months).
- Tell any doctor planning surgery or a scan with iodinated contrast dye that you take metformin; it may have to be paused (see the safety section below).
- Keep to the diet and exercise plan your doctor gave you. Metformin works alongside it, not instead of it.
Lower doses and extra care for some groups
- Kidney function. The US ER label: contraindicated below an eGFR of 30; starting it at 30 to 45 "is not recommended"; if eGFR falls below 45 during treatment, the doctor should weigh the benefit and risk of continuing, and stop it below 30 (2.4). The UK Glucophage SR label caps the total daily dose by kidney function: 2,000 mg at a GFR of 60 to 89 and also at 45 to 59 (where the starting dose is at most half the maximum), and 1,000 mg (two Glycomet 500 SR tablets) at 30 to 44 (4.2).
- Children. This is a clear difference from standard tablets. The US ER label says safety and effectiveness in pediatric patients "have not been established" (8.4), and the UK label says: "In the absence of available data, Glucophage SR should not be used in children." Glycomet 500 SR is not a children's medicine.
- Older people. The US ER label advises cautious dose selection, usually at the low end of the range, and more frequent kidney checks (8.5). The US patient information says people over 80 should not take it unless their kidneys have been checked and are normal.
- Liver disease. "Not recommended" in the US ER label (8.7); hepatic insufficiency is a contraindication in the UK label (4.3).
- Heart failure. The UK label allows metformin in stable chronic heart failure with regular heart and kidney monitoring, and contraindicates it in acute and unstable heart failure (4.4). The US ER label names acute congestive heart failure as a lactic acidosis risk (5.1).
- Sick days. The UK label says that with dehydration from severe diarrhoea or vomiting, fever or reduced fluid intake, "metformin should be temporarily discontinued and contact with a health care professional is recommended" (4.4).
Lactic acidosis: the boxed warning
US extended release metformin carries a boxed warning. The current US ER label begins: "Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of metformin associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain."
The same box lists the risk factors: kidney impairment, certain medicines (for example carbonic anhydrase inhibitors such as topiramate), age 65 or over, X-ray studies with contrast, surgery and other procedures, low oxygen states such as acute congestive heart failure, excessive alcohol intake, liver impairment and mitochondrial diseases. The UK Glucophage SR label calls lactic acidosis "a very rare, but serious, metabolic complication" and adds inadequately controlled diabetes, ketosis and prolonged fasting as risk factors (4.4).
What it feels like, in the words of the US ER patient information: feeling very weak and tired, unusual muscle pain, trouble breathing, unusual sleepiness, unexplained stomach or intestinal problems with nausea and vomiting or diarrhoea, feeling cold especially in the arms and legs, dizziness or lightheadedness, and a slow or irregular heartbeat. The patient information says to stop the tablets and call your healthcare provider right away; it calls lactic acidosis "a medical emergency" that "must be treated in the hospital". The UK label says: "In case of suspected symptoms, the patient should stop taking metformin and seek immediate medical attention." (4.4)
Scans and operations. For iodinated contrast, the US ER label says to stop metformin at the time of, or before, the scan in people with an eGFR of 30 to 60, a history of liver disease, alcoholism or heart failure, or who will get contrast into an artery, and to recheck eGFR 48 hours later before restarting (2.5). The UK label says to stop it before or at the time of the scan and not restart for at least 48 hours, once kidney function is rechecked and stable, and that it "must be discontinued at the time of surgery under general, spinal or epidural anaesthesia" (4.4). A once daily evening tablet is easy to forget to pause, so tell the team that you take it.
Side effects
The US ER label pools placebo-controlled trials in which 781 adults took metformin extended release and 195 took placebo. Table 1 lists every reaction reported in more than 5% of people on the drug and more often than on placebo:
| Side effect | Metformin ER (n=781) | Placebo (n=195) |
|---|---|---|
| Diarrhoea | 10% | 3% |
| Nausea or vomiting | 7% | 2% |
Diarrhoea made 0.6% of people stop (US ER label 6.1). Reactions reported in 1% to 5% and more often than on placebo were abdominal pain, constipation, abdominal distension, indigestion or heartburn, flatulence, dizziness, headache, upper respiratory infection and taste disturbance. These rates come from extended release trials and should not be read side by side with rates from separate trials of standard tablets. The UK Glucophage SR label says side effect reports with the slow release form were "similar in nature and severity" to those with immediate release Glucophage, that nausea, vomiting, diarrhoea, abdominal pain and loss of appetite are most common at the start and "resolve spontaneously in most cases", and lists vitamin B12 decrease and taste disturbance as common, with liver test changes, hepatitis and skin reactions (redness, itching, hives) as very rare (4.8).
Vitamin B12. The US ER label (5.2) describes a fall to below normal B12 levels in about 7% of people in 29 week trials of standard metformin tablets, and advises yearly blood counts and a B12 check every 2 to 3 years. The UK label (4.4) says the risk "increases with increasing metformin dose, treatment duration", and that B12 should be checked if deficiency is suspected (anaemia or neuropathy).
Low blood sugar. Metformin on its own does not normally cause it; the UK label says "Metformin alone never causes hypoglycaemia" (4.4). With insulin or a sulfonylurea the risk rises, and a lower dose of the other medicine may be needed (US ER label 5.3).
Effect on HbA1c. In a 16 week US dose-response trial in people not controlled by diet and exercise, HbA1c fell by 0.4 points on 500 mg once daily, 0.6 on 1,000 mg, 0.9 on 1,500 mg and 0.8 on 2,000 mg once daily, and by 1.1 on 1,000 mg twice daily, against a rise of 0.1 on placebo, from baselines of 8.2% to 8.4% (US ER label 14.2, Table 6). A single 500 mg SR tablet a day had the smallest effect in that trial, which is one reason the labels build the dose up.
When to get urgent help
Call emergency services or go to an emergency department, or get someone to take you, if you have:
- Possible lactic acidosis: severe weakness, unusual muscle pain, trouble breathing, unusual drowsiness, feeling cold, dizziness, a slow or irregular heartbeat, or stomach pain with vomiting or diarrhoea. Stop taking Glycomet SR; this needs hospital treatment.
- Taken more tablets than prescribed. The US ER patient information says to call your healthcare provider or local Poison Control Center, or go to the nearest hospital emergency room right away; the US ER label (10) reports lactic acidosis in about 32% of metformin overdose cases and lists the US Poison Help line, 1-800-222-1222.
- A low blood sugar episode that does not settle with sugar, keeps coming back, or causes confusion, a fit or unconsciousness (mainly a risk alongside insulin or a sulfonylurea). Do not give food or drink to someone who cannot swallow safely (general first aid).
- Swelling of the face, lips, tongue or throat, trouble breathing or swallowing, or a spreading rash or hives. Allergy to metformin is a contraindication in both labels; acting on these signs is our general safety advice.
- Yellowing of the skin or eyes, dark urine or pale stools. The US ER label reports liver injury after marketing (6.2); the warning signs are our general advice.
Tell the emergency team that you take slow release metformin (Glycomet 500 SR), how many tablets and when you last took them, and which other diabetes medicines you use. A slow release tablet keeps releasing metformin for hours, so the timing helps them.
Who should not take Glycomet 500 SR
Never take it if (label named for each item):
- you are allergic to metformin or any ingredient of the tablet (US ER label 4; UK label 4.3)
- your eGFR is below 30 mL/min (US ER label 4; UK label 4.3)
- you have acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma (US ER label 4); any type of acute metabolic acidosis or diabetic pre-coma (UK label 4.3)
- you have an acute condition that can affect the kidneys, such as dehydration, severe infection or shock (UK label 4.3)
- you have an illness that can starve tissues of oxygen, such as decompensated heart failure, respiratory failure, a recent heart attack or shock (UK label 4.3)
- you have hepatic insufficiency, acute alcohol intoxication or alcoholism (UK label 4.3)
Not recommended, or only with your doctor's close supervision:
- children: not established in the US ER label (8.4); "should not be used in children" (UK label 4.2)
- starting it at an eGFR of 30 to 45: "not recommended" (US ER label 2.4)
- liver impairment: "not recommended" (US ER label 8.7)
- known mitochondrial disease such as MELAS or MIDD: "not recommended" (US ER label 5.1; UK label 4.4)
- type 1 diabetes: the US ER patient information says the tablets "should not be used to treat people with type 1 diabetes"
- age over 80 without a normal kidney check (US ER patient information)
- heavy or binge drinking: the US ER label tells prescribers to warn patients against excessive alcohol intake
Pregnancy and breastfeeding. The UK Glucophage SR label (4.6) says that, if clinically needed, metformin "can be considered during pregnancy and in the periconceptional phase as an addition or an alternative to insulin", and that "breastfeeding is not recommended during metformin treatment", with the decision weighing the benefit of breastfeeding against possible risk to the child. The US ER label says data in pregnancy are not sufficient to determine a drug-associated risk, while published studies have not shown a clear link with major birth defects or miscarriage (8.1), and that the benefits of breastfeeding should be weighed against the mother's need for the medicine (8.2). The US ER label also notes that metformin may lead to ovulation in some premenopausal women who do not ovulate, which may lead to an unintended pregnancy (8.3, 17). Plan any pregnancy with your doctor.
Other UK uses. Unlike the US ER labels, which cover only type 2 diabetes in adults, the UK Glucophage SR label also covers reducing the risk of type 2 diabetes in high risk overweight adults after 3 to 6 months of intensive lifestyle change, and ovulation stimulation in women with polycystic ovary syndrome (4.1). Both are decisions for a doctor, not reasons to start slow release metformin on your own.
Medicines that interact
- Carbonic anhydrase inhibitors (topiramate, zonisamide, acetazolamide, dichlorphenamide): may raise the lactic acidosis risk; the US ER label advises more frequent monitoring (7).
- Medicines that slow metformin's removal by the kidney: the US ER label names ranolazine, vandetanib, dolutegravir and cimetidine (7). The UK label's list of OCT2 inhibitors adds trimethoprim and isavuconazole, names crizotinib and olaparib as affecting both OCT1 and OCT2, and says verapamil may reduce metformin's efficacy while rifampicin may increase it; caution especially with kidney impairment (4.5).
- Medicines that can strain the kidneys: NSAID painkillers including COX-2 inhibitors, ACE inhibitors, angiotensin II receptor antagonists and diuretics, especially loop diuretics; the UK label says close monitoring of kidney function is necessary (4.5).
- Insulin and sulfonylureas: more risk of low blood sugar; a lower dose of the other medicine may be needed (US ER label 7).
- Medicines that push blood glucose up: thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blockers and isoniazid (US ER label 7). Watch readings when one is started or stopped.
- Alcohol: potentiates metformin's effect on lactate (US ER label 7). The UK label lists alcohol under "Concomitant use not recommended", because intoxication raises the lactic acidosis risk, particularly with fasting, malnutrition or liver impairment (4.5).
Give your doctor and pharmacist a full list of your medicines and supplements before you start.
Prescription and legal status
Slow release metformin is prescription-only in every country we ship to. In the US, generic metformin ER tablets are prescription medicines, and Glucophage XR is discontinued. In the UK, Glucophage SR 500 mg is licensed to Merck Serono (PL 11648/0054), and the NHS says metformin is available only on prescription. In Australia, healthdirect lists Diabex XR (500 mg, 750 mg and 1 g) as "Schedule 4: Prescription Only Medicine". In Canada, the Health Canada Drug Product Database lists Glumetza 500 mg extended release (DIN 02268493) as marketed, with a prescription schedule. In India, the Apollo listing marks Glycomet 500 SR as a "Prescription Medicine" and Medkart shows a "Prescription Required" badge.
The Indian Glycomet 500 SR pack is not registered with the FDA, MHRA, TGA or Health Canada. The FDA says personal importation of unapproved medicines is illegal in most circumstances. Check the rules where you live before you order.
Buying genuine Glycomet 500 SR
The MHRA warns: "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It also advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo". Glycomet 500 SR is not authorised in the UK, so that warning applies to it.
When your parcel arrives, check that the strips say Glycomet-500 S.R. or sustained release, metformin hydrochloride 500 mg and USV Private Limited, with a batch number and expiry date. If the strip shows plain "Metformin Hydrochloride Tablets" with no SR wording, it is the standard tablet, which is taken differently, so contact us before taking it. None of these checks can prove the tablets are genuine, because packaging can be copied. Watch your glucose readings for the first weeks on any new supply. If a batch seems to cause unusual symptoms, get medical advice and report it to your regulator (the MHRA Yellow Card scheme, FDA MedWatch, the TGA or Health Canada) as well as to us.
Storage: PharmEasy says to keep Glycomet SR 500 in a cool, dry place away from sunlight, moisture and heat; Apollo says controlled room temperature, ideally 20 to 25 C, in the original packaging; Medkart says room temperature and, in its FAQ, below 25 C. None of the listings mentions refrigeration. Follow the carton.
Delivery
We ship Glycomet 500mg SR to the US, UK, Australia and Canada in plain packaging, with tracking. Delivery takes 7 to 14 business days. Shipping is $25 on orders under $149 and free from $149. Order before your current strips run low, because running out of a daily diabetes tablet for two weeks is not a safe gap; do not cut doses to stretch your supply. Details are on our shipping page and in our refund policy.
Related guides
- Metformin dosage guide: starting doses, titration steps and maximum daily limits
- Metformin side effects: trial incidence rates, GI timing and B12 monitoring
- Metformin for PCOS: treatment guide for women
- Metformin vs glimepiride: how the two oral diabetes tablets differ
Related products: Glycomet 500mg (standard release), Glycomet 850mg SR, Metsmall 1000 SR.
Sources
- Metformin hydrochloride extended-release tablets USP 500 mg, US prescribing information and Patient Information, Ascend Laboratories (made by Inventia Healthcare, India) (DailyMed setid a944a167-e3ac-4084-af1c-22b48713471c, SPL version 12, effective 21 September 2026): boxed warning, sections 1, 2.2 to 2.5, 4, 5.1 to 5.4, 6.1, 6.2, 7, 8.1 to 8.7, 10, 12.3, 14.2, 17. DailyMed
- Glucophage SR 500 mg, 750 mg and 1000 mg prolonged release tablets, UK SmPC, Merck Serono, text revised 13 March 2025 (emc updated 31 March 2025): sections 4.1 to 4.9, 5.1, 5.2, 8. emc
- Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC) 2026, file as of 4 November 2026: METFORMIN HCL ER 500 MG TABLET, 31 NDC rows at $0.02841; METFORMIN ER 500 MG OSMOTIC TB, 9 rows at $0.18913; METFORMIN ER 500 MG GASTRC-TB, 6 rows at $0.28306; all effective 21 October 2026. data.medicaid.gov
- US Food and Drug Administration, openFDA drug approvals: Glucophage XR (NDA 021202), 500 mg and 750 mg discontinued, Federal Register determination that it was not discontinued for reasons of safety or effectiveness.
- Health Canada Drug Product Database: Glumetza 500 mg, DIN 02268493, marketed, prescription, checked 10 November 2026. Health Canada
- healthdirect Australia: Diabex XR (metformin), Schedule 4 Prescription Only Medicine. healthdirect
- NHS. Metformin. NHS
- Indian pharmacy listings for Glycomet SR 500 (PharmEasy strip of 20 and strip of 10, Apollo Pharmacy, Medkart), checked 10 November 2026, and the carton in our product photo.
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is general information, not medical advice. Glycomet 500 SR is a prescription diabetes medicine. Use it only as prescribed by a doctor who checks your blood glucose, HbA1c and kidney function, and do not start, stop or switch between standard and slow release metformin without that doctor.
Frequently asked questions
What is Glycomet 500 SR?
Glycomet 500 SR is a slow (sustained) release metformin hydrochloride 500 mg tablet from USV Private Limited in India, used with diet and exercise to lower blood glucose in adults with type 2 diabetes. The carton in our product photo reads "Metformin Hydrochloride Sustained Release Tablets IP 500 mg". Slow release metformin is licensed in the US, UK, Australia and Canada, but this Indian pack is not registered with the FDA, MHRA, TGA or Health Canada.
How is Glycomet 500 SR different from Glycomet 500?
Both contain 500 mg of metformin. The SR tablet releases it slowly, so it is taken once a day with the evening meal, while standard Glycomet 500 is usually taken two or three times a day with meals. The US extended release and UK Glucophage SR labels allow a switch at the same total daily dose, but only your doctor should make that change. Our SR tablet also costs about 1.7 to 2 times as much as our standard Glycomet 500mg.
How much does Glycomet 500 SR cost per tablet?
As of November 2026, $0.66 a tablet in the 100 pack, $0.64 in the 200 pack and $0.62 in the 300 pack, before shipping; the pack selector shows the current price. Shipping is $25 under $149 and free from $149, which makes the 300 pack $0.62 a tablet delivered. In the US, plain generic metformin ER 500 mg costs pharmacies about 3 cents a tablet (NADAC $0.02841, effective 21 October 2026), so US buyers with a prescription will very likely pay less locally.
How do I take Glycomet 500 SR?
Usually once a day with the evening meal, swallowed whole with water. The US extended release label says to swallow the tablets whole and never crush, cut or chew them. If you miss a dose, do not take two doses on the same day; take the next dose at the usual time. Your doctor sets the number of tablets.
What is the starting and maximum dose?
Both the US extended release label and the UK Glucophage SR label start with one 500 mg tablet once daily with the evening meal and raise the dose by 500 mg (weekly in the US label, every 10 to 15 days in the UK label) up to 2,000 mg once daily, which is four Glycomet 500 SR tablets. If 2,000 mg once daily is not enough, both labels mention 1,000 mg twice daily (the UK label says with food); doses above 2,000 mg a day mean switching to standard metformin tablets.
Why did I see a whole tablet in my stool?
The US extended release patient information says you may sometimes pass a soft mass that looks like the tablet, and that this is not harmful and does not affect how the medicine works. The UK Glucophage SR label says the tablet shells may be present in the faeces and that this is normal. These statements come from the US and UK products; we could not see USV's own leaflet. If your glucose readings rise at the same time, tell your doctor.
Does slow release metformin cause fewer stomach side effects?
It is often used for that reason, but the labels do not compare the two forms head to head for side effects. In US placebo-controlled extended release trials, diarrhoea affected 10% (against 3% on placebo) and nausea or vomiting 7% (against 2%). The UK Glucophage SR label says side effects were similar in nature and severity to standard Glucophage and usually settle on their own after the start of treatment.
Is Glycomet 500 SR safe for children?
No. The US extended release label says safety and effectiveness in pediatric patients have not been established, and the UK Glucophage SR label says that in the absence of data it should not be used in children. Standard metformin tablets, not the slow release form, are the ones labelled for children aged 10 and over.
Who should not take Glycomet 500 SR?
Anyone allergic to metformin, anyone with an eGFR below 30, metabolic acidosis including diabetic ketoacidosis, and (in the UK label) people with dehydration, severe infection, shock, decompensated heart failure, respiratory failure, a recent heart attack, liver insufficiency, acute alcohol intoxication or alcoholism. Starting it at an eGFR of 30 to 45, liver impairment and mitochondrial disease such as MELAS or MIDD are "not recommended" in the US label. It is not for type 1 diabetes.
What is lactic acidosis and what are the warning signs?
Lactic acidosis is a rare but dangerous build-up of acid in the blood and is the subject of the US boxed warning. Signs include severe weakness or tiredness, unusual muscle pain, trouble breathing, unusual sleepiness, feeling cold, dizziness, a slow or irregular heartbeat, and stomach pain with nausea, vomiting or diarrhoea. The US patient information says to stop the tablets and call your healthcare provider right away, and that lactic acidosis must be treated in the hospital; the UK label says to stop metformin and seek immediate medical attention.
Do I need a prescription, and how long does delivery take?
Slow release metformin is prescription-only in the US, UK, Australia and Canada, and Indian listings also mark Glycomet 500 SR as needing a prescription. The FDA says personal importation of unapproved medicines is illegal in most circumstances, so check your local rules. We ship in plain, tracked packaging in 7 to 14 business days; order before your current supply runs out.
Medical References
- 1.Metformin hydrochloride extended-release tablets USP 500 mg, US prescribing information and Patient Information, Ascend Laboratories (DailyMed SPL version 12, effective 21 September 2026) — 2026
- 2.Glucophage SR 500 mg, 750 mg and 1000 mg prolonged release tablets, UK Summary of Product Characteristics (Merck Serono, text revised 13 March 2025; emc updated 31 March 2025) — 2025
- 3.CMS National Average Drug Acquisition Cost (NADAC) 2026, metformin ER 500 mg tablet rows effective 21 October 2026, file as of 4 November 2026 — 2026
- 4.healthdirect Australia: Diabex XR (metformin extended release), Schedule 4 Prescription Only Medicine
- 5.NHS: Metformin
- 6.US Food and Drug Administration: Personal Importation
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Glycomet 500mg SR? Tell other buyers how it went.









